Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 4/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.36 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17720604 | 1.00 | AHR (0.39) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720655 | 0.99 | PLA2G2A (0.40) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720663 | 0.97 | PLA2G2A (0.39) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720622 | 0.97 | ALOX5 (0.40) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720658 | 0.97 | ALOX5 (0.40) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL18854425 | 0.96 | MMP12 (0.40) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL18854418 | 0.96 | MMP12 (0.40) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720617 | 0.96 | ALOX5 (0.41) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720661 | 0.96 | PLA2G2A (0.42) | AHRPLA2G2APLA2G4AMMP12MMP13 | |
| SCHEMBL17720669 | 0.95 | AHR (0.39) | AHRPLA2G2APLA2G4AMMP12MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9947875-B2 | Amine derivatives, material for organic electroluminescent device and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-17 | — | — | US | disclosed |
| US-9947875-B2 | Amine derivatives, material for organic electroluminescent device and organic electroluminescent device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-04-17 | — | — | US | disclosed |
| US-20160126467-A1 | AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
| US-20160126467-A1 | AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126467-A1 | AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | PNMT, ODC1, ALKBH1 | AHR 1159/4885PLA2G2A 3918/4885PLA2G4A 4375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.